Added to YB: 2026-06-24
Pitch date: 2026-06-21
TEM [bullish]
Tempus AI, Inc.
Author Info
No bio for this author
Company Info
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$8.6B
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-54.32
P/E
-27.77
EV/Sales
6.80
Sector
Life Sciences Tools and Services
Category
growth
Tempus AI: Building the Operating System for Precision Oncology — Why It Outpaces Guardant Health and Caris Life Sciences
TEM: Precision oncology platform vs peers Guardant/Caris. Q1'26 rev $348M (+36% YoY), raised FY guide to $1.59-1.60B, ~$65M adj EBITDA. Largest multimodal oncology dataset; high-margin data/AI licensing growing 40%+. Trades ~half GH market cap on stronger guidance. Risks: cash burn, SBC, IP litigation w/ Guardant, reimbursement, AI regulation. Bull: platform re-rating as moat widens.
Read full article (5 min)